Results 31 to 40 of about 16,013 (232)
Mineral and bone disorders secondary to chronic kidney disease (renal osteodystrophy)
Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 2015 Chronic kidney disease (CKD) in paediatric population gives rise to complex of diseases that is known as chronic kidney disease-mineral and bone disorder (CKD-MBD), which mainly involves the calcium and bone metabolism.
Alphonsus N. Onyiriuka +7 more
doaj +1 more source
F1000Research, 2020 Secondary hyperparathyroidism is a complex pathology that develops as chronic kidney disease progresses. The retention of phosphorus and the reductions in calcium and vitamin D levels stimulate the synthesis and secretion of parathyroid hormone as well ...
María E. Rodríguez-Ortiz +1 more
doaj +1 more source
Radiographic manifestations of abnormal bone and mineral metabolism in end‐stage renal disease
Clinical Case Reports, 2019 Key Clinical Message Chronic kidney disease‐mineral and bone disorder (CKD‐MBD) refers to a broader clinical syndrome that develops as a systemic disorder due to CKD, manifested by abnormalities in bone and mineral metabolism and/or extraskeletal ...
Abhilash Koratala +2 more
doaj +1 more source
Bone Histo-Morphology in Chronic Kidney Disease Mineral Bone Disorder [PDF]
Indian Journal of Hematology and Blood Transfusion, 2016 Chronic Kidney Disease-Mineral Bone Disorder(CKD-MBD) is a systemic disorder of the mineral and bone metabolism seen in patients with Chronic Kidney Disease(CKD). It is manifested by either one or a combination of the following: (a) Abnormalities of calcium, phosphorus, PTH, or vitamin D metabolism.
Khuraijam Bembem +4 more
openaire +2 more sources
New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province
BMJ OpenObjectives To seek a triple combination of biomarkers for early diagnosis of chronic kidney disease-mineral and bone metabolic disorder and to explore the diagnostic efficacy of β2-microglobulin, parathyroid hormone and blood urea nitrogen in chronic ...
Yun Zhou +9 more
doaj +1 more source
A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum
Scientific Reports, 2017 Calciprotein particles, nanoscale aggregates of insoluble mineral and binding proteins, have emerged as potential mediators of phosphate toxicity in patients with Chronic Kidney Disease.
Edward R. Smith +6 more
doaj +1 more source
Health Technology Assessment, 2021 Background: Bisphosphonates are contraindicated in patients with stage 4+ chronic kidney disease. However, they are widely used to prevent fragility fractures in stage 3 chronic kidney disease, despite a lack of good-quality data on their effects ...
Danielle E Robinson +13 more
doaj +1 more source
Advanced Healthcare Materials, EarlyView.Efficient recovery from traumatic or degenerative diseases is a great challenge, even after all the advancements in bone and cartilage regeneration. Machine learning (ML) algorithms have presented opportunities to enhance these aspects by accurately analyzing imaging data.
Maryam Kamaei +9 more
wiley +1 more source
Advanced Science, EarlyView.Mechanical stress activates BAP31 in chondrocytes. BAP31 competes with ATG14 for binding to STX17, disrupting the STX17–ATG14 complex required for autophagosome–lysosome fusion. The resultant autophagic flux blockade drives the generation of autophagy‐derived exosomes, which mediate pathological cartilage calcification in OA. Chondrocyte‐targeted BAP31
Zhi‐hua Xu +13 more
wiley +1 more source
Chronic Kidney Disease—Mineral and Bone Disorder (CKD-MBD), from Bench to Bedside
Kidney and Dialysis, 2023 Chronic kidney disease—mineral and bone disorder (CKD-MBD) is a systemic disorder that increases the risk of morbidity and mortality in dialysis patients.
Kosaku Nitta +4 more
doaj +1 more source